Lars Ekblad
Impact in
-
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
-
- Thyroid Cancer Diagnosis and Treatment
Papers in
-
- Lipid Membrane Structure and Behavior 3
- Glycosylation and Glycoproteins Research 2
- Oncology 8
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Charlotte Welinder (2 shared papers)Anders Johnsson (4 shared papers)Johan Wennerberg (9 shared papers)Bengt Jergil (5 shared papers)Elisabeth Kjellén (9 shared papers)Johan Wennerberg (10 shared papers)Hiroyuki Mineta (4 shared papers)Kajsa Paulsson (3 shared papers)
In The Last Decade
Lars Ekblad
35 papers receiving 903 citations
Peers
Comparison fields: 5 of 111
- Oncology 170
- Endocrinology, Diabetes and Metabolism 91
- Otorhinolaryngology 22
- Cell Biology 90
- Molecular Biology 371
Countries citing papers authored by Lars Ekblad
This map shows the geographic impact of Lars Ekblad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Ekblad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Ekblad more than expected).
Fields of papers citing papers by Lars Ekblad
This network shows the impact of papers produced by Lars Ekblad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Ekblad. The network helps show where Lars Ekblad may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Ekblad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 386 | |
| 2 | 2018 | 52 | |
| 3 | 2014 | 50 | |
| 4 | 2017 | 36 | |
| 5 | 2019 | 34 | |
| 6 | 2008 | 33 | |
| 7 | 2010 | 31 | |
| 8 | 2018 | 27 | |
| 9 | 2011 | 20 | |
| 10 | 1999 | 19 | |
| 11 | 2019 | 17 | |
| 12 | 2017 | 16 | |
| 13 | 2009 | 16 | |
| 14 | 1997 | 16 | |
| 15 | 2018 | 14 | |
| 16 | 2000 | 14 | |
| 17 | Cetuximab sensitivity associated with oxaliplatin resistance in colorectal cancer. | 2012 | 13 |
| 18 | 2001 | 12 | |
| 19 | 2017 | 12 | |
| 20 | 2020 | 10 |
About Lars Ekblad
Lars Ekblad is a scholar working on Molecular Biology, Oncology, Cell Biology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 912 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (4 papers), Cellular transport and secretion (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Lipid Membrane Structure and Behavior (3 papers), Glycosylation and Glycoproteins Research (2 papers), Microfluidic and Bio-sensing Technologies (2 papers), Medical Imaging Techniques and Applications (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Oncology (170 citations), Endocrinology, Diabetes and Metabolism (91 citations), Otorhinolaryngology (22 citations), Cell Biology (90 citations) and Molecular Biology (371 citations). Lars Ekblad has collaborated with scholars based in Sweden, Japan and Denmark. Frequent co-authors include Charlotte Welinder, Anders Johnsson, Johan Wennerberg, Bengt Jergil, Elisabeth Kjellén, Johan Wennerberg, Hiroyuki Mineta, Kajsa Paulsson, C. Christofer Juhlin and Catharina Larsson. Their work appears in journals such as BMC Cancer, Oral Oncology, Journal of Cancer Research and Clinical Oncology, Analytical Biochemistry and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.